191 related articles for article (PubMed ID: 23811447)
41. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the Antibacterial Activity of the Ethanol Extract vs Hydroalcoholic Extract of the Leaves of
Cardenas V; Mendoza R; Chiong L; Del Aguila E; Alvítez-Temoche D; Mayta-Tovalino F
J Contemp Dent Pract; 2020 Feb; 21(2):202-206. PubMed ID: 32381828
[TBL] [Abstract][Full Text] [Related]
43. In vitro antibacterial activity of Psidium guajava Linn. leaf extract on clinical isolates of multidrug resistant Staphylococcus aureus.
Anas K; Jayasree PR; Vijayakumar T; Manish Kumar PR
Indian J Exp Biol; 2008 Jan; 46(1):41-6. PubMed ID: 18697570
[TBL] [Abstract][Full Text] [Related]
44. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
[TBL] [Abstract][Full Text] [Related]
45. Screening of the Dichloromethane: Methanolic Extract of
Sieberi BM; Omwenga GI; Wambua RK; Samoei JC; Ngugi MP
ScientificWorldJournal; 2020; 2020():6378712. PubMed ID: 32694956
[TBL] [Abstract][Full Text] [Related]
46. Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
Pal NK; Mandal S; Mandal MD
Int J Antimicrob Agents; 2004 Sep; 24(3):297-9. PubMed ID: 15325437
[TBL] [Abstract][Full Text] [Related]
47. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
48. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
[TBL] [Abstract][Full Text] [Related]
49. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
[TBL] [Abstract][Full Text] [Related]
50. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates.
Abdullah FE; Haider F; Fatima K; Irfan S; Iqbal MS
J Coll Physicians Surg Pak; 2012 Mar; 22(3):147-50. PubMed ID: 22414353
[TBL] [Abstract][Full Text] [Related]
51. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance.
Malla S; Kansakar P; Serichantalergs O; Rahman M; Basnet S
JNMA J Nepal Med Assoc; 2005; 44(157):18-22. PubMed ID: 16082406
[TBL] [Abstract][Full Text] [Related]
53. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial screening of some Egyptian plants and active flavones from Lagerstroemia indica leaves.
Diab Y; Atalla K; Elbanna K
Drug Discov Ther; 2012 Aug; 6(4):212-7. PubMed ID: 23006992
[TBL] [Abstract][Full Text] [Related]
55. [Sensitivity to antibiotics of Salmonella typhi and paratyphi strains isolated in Algeria 1979-1984].
Zoukh K
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):608-10. PubMed ID: 3534753
[TBL] [Abstract][Full Text] [Related]
56. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
58. Antibacterial activities of medicinal plants used for the treatment of diarrhoea in Limpopo Province, South Africa.
Mathabe MC; Nikolova RV; Lall N; Nyazema NZ
J Ethnopharmacol; 2006 Apr; 105(1-2):286-93. PubMed ID: 16545928
[TBL] [Abstract][Full Text] [Related]
59. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
Verma S; Thakur S; Kanga A; Singh G; Gupta P
Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
[TBL] [Abstract][Full Text] [Related]
60. Phage-antibiotic synergism against Salmonella typhi isolated from stool samples of typhoid patients.
Ali S; Aslam MA; Kanwar R; Mehmood Z; Arshad MI; Hussain S
Ir J Med Sci; 2024 Jun; 193(3):1377-1384. PubMed ID: 38158479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
